You searched for "IoL"
In conversation with Iqbal K Ahmed - From across the Atlantic
Ike (Iqbal) K Ahmed is a pioneering ophthalmologist from Canada, currently serving as Assistant Professor at the University of Toronto, and Clinical Assistant Professor at the University of Utah. He is also the Research Fellowship Director, Department of Ophthalmology, University...The art of ophthalmic simulations
For Dec/Jan 2024, I got in touch with Nicky Webster, a Principal 3D Artist at FundamentalVR (https://fundamentalsurgery.com). Nicky is also a registered medical illustrator, healthcare scientist and medical photographer. With over 18 years of experience working in various disciplines within...Origami and ophthalmology: precision unfolded
For Eye News Feb/Mar 2024, I was delighted to hear from Dr Hosam Aglan. In New Zealand at the time, Dr Aglan shared wonderful insights into the art of folding origami, along with images from his own creations. The role...World-first artificial intelligence foundation model for eye care to supercharge global efforts to prevent blindness
Researchers at Moorfields Eye Hospital and UCL Institute of Ophthalmology (IoO) have developed an artificial intelligence (AI) system that has the potential to not only identify sight-threatening eye diseases but also predict general health, including heart attacks, stroke and Parkinson’s disease.Real-world experience and outcomes of SLT laser used as a first-line treatment in ocular hypertension patients in a United Kingdom National Health Service setting
The management of raised intraocular pressure (IOP) in the context of ocular hypertension (OHT) and primary open angle glaucoma (POAG) remains a major contributor to the workload of ophthalmology units across the UK. Treatment of these conditions has historically centred...Refined glaucoma referral practice offers prospect of improved capacity and expanded role for primary eye care professionals
Glaucoma is the most frequent cause of irreversible blindness worldwide and the second leading cause of blindness in the UK [1,2]. The global prevalence of glaucoma in 2010 was approximately 3.5% for people aged 40-80 years, according to Jonas et...Could the sclera be key to glaucoma?
The glaucomas are a group of conditions characterised by optic neuropathy and associated visual field defects. Of these, chronic open-angle glaucoma (COAG) – diagnosed on the basis of progressive structural changes to the optic nerve head (ONH) and nerve fibre...Childhood glaucoma
When a child is given a diagnosis of glaucoma, the impact upon that child and their family is enormous; equivalent to the diagnosis of a cancer [14]. This previously published article (2019) outlines the knowledge, techniques and approaches that offer...A closer look at the new wave of glaucoma surgery – radical or old school?
Glaucoma is a challenging condition to treat because the exact pathophysiology remains unclear and the only readily modifiable factor is the intraocular pressure (IOP). Additionally, most glaucoma patients are completely asymptomatic, yet are often subjected to lifelong medical therapy. The...RCOphth 2024 Report
A comprehensive tapestry of all our RCOphth Annual Congress content captured between 20–23 May 2024.
Intravitreal triamcinolone for uveitic macular oedema
This paper from South Korea reports on a prospective, double blind, randomised clinical study designed to evaluate the additional benefit of intravitreal triamcinolone (TA) administration for noninfectious uveitic macular oedema as an adjunct therapy to systemic anti-inflammatory treatment. Patients were...
